Drug Profile
Naftifine gel - MediQuest Therapeutics
Alternative Names: IVR-102; MQX-5858; MQX-5859; Organogel (naftidine) - MediQuest Therapeutics; Organogel of naftifine 2% or 6%Latest Information Update: 26 Jul 2016
Price :
$50
*
At a glance
- Originator MediQuest Therapeutics
- Class Allylamines; Antifungals; Naphthalenes; Small molecules
- Mechanism of Action Squalene monooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Onychomycosis
Most Recent Events
- 26 Jul 2016 Discontinued - Phase-II for Onychomycosis in USA (Topical)
- 01 Feb 2009 No recent reports on development identified - Phase-II for Onychomycosis in USA (Topical)